Glen Harbor Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$378K Hold
10,098
0.01% 803
2019
Q2
$440K Hold
10,098
0.01% 740
2019
Q1
$431K Hold
10,098
0.01% 732
2018
Q4
$452K Hold
10,098
0.01% 654
2018
Q3
$692K Buy
+10,098
New +$650K 0.01% 592
2018
Q2
Sell
-7,888
Closed -$363K 1270
2018
Q1
$363K Hold
7,888
0.01% 757
2017
Q4
$364K Buy
7,888
+1,224
+18% +$56.3K 0.01% 768
2017
Q3
$300K Buy
6,664
+748
+13% +$31.9K 0.01% 765
2017
Q2
$232K Buy
5,916
+2,686
+83% +$101K 0.01% 819
2017
Q1
$123K Buy
3,230
+34
+1% +$1.32K ﹤0.01% 873
2016
Q4
$118K Buy
+3,196
New +$114K ﹤0.01% 856

Other funds holding AVNS

Glen Harbor Capital Management's AVNS Position: Q3 2019 in Review

Glen Harbor Capital Management held its Avanos Medical (AVNS) position steady in Q3 2019 at 10,098 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #803.

Glen Harbor Capital Management first reported a position in AVNS in Q4 2016 and has held it in 11 quarters since. The position peaked at $692K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Glen Harbor Capital Management held 10,098 shares of Avanos Medical worth $378K as of Q3 2019.
  • Glen Harbor Capital Management left its Avanos Medical share count unchanged in Q3 2019.
  • Avanos Medical made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #803 holding.
  • Glen Harbor Capital Management first reported a position in Avanos Medical in Q4 2016 and has held it in 11 quarters since.
  • Glen Harbor Capital Management's Avanos Medical position peaked at $692K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.